Scarica l'app Stockscreener
0.4846
82.44%
-2.2754
Dopo l'orario di chiusura:
.49
0.0054
+1.11%
Precedente Chiudi:
$2.76
Aprire:
$0.55
Volume 24 ore:
46.02M
Relative Volume:
33.13
Capitalizzazione di mercato:
$71.33M
Reddito:
-
Utile/perdita netta:
$-54.17M
Rapporto P/E:
-1.3101
EPS:
-0.3699
Flusso di cassa netto:
$-39.34M
1 W Prestazione:
-82.44%
1M Prestazione:
-81.64%
6M Prestazione:
-70.45%
1 anno Prestazione:
-72.31%
Intervallo 1D:
$0.4575
$0.5592
Intervallo di 1 settimana:
$0.4575
$0.5592
Portata 52W:
$0.4575
$3.5299
Immutep Limited Adr Stock (IMMP) Company Profile
Nome
Immutep Limited Adr
Settore
Industria
Telefono
-
Indirizzo
-
Compare IMMP vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IMMP
Immutep Limited Adr
|
0.4846 | 71.33M | 0 | -54.17M | -39.34M | -0.3699 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.34 | 119.23B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.77 | 78.84B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
700.45 | 43.35B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.41 | 41.57B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.05 | 31.51B | 5.36B | 287.73M | 924.18M | 2.5229 |
Immutep Limited Adr Stock (IMMP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-13 | Downgrade | Citizens | Mkt Outperform → Mkt Perform |
| 2026-03-13 | Downgrade | Maxim Group | Buy → Hold |
| 2026-03-13 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2026-02-17 | Iniziato | Citizens | Mkt Outperform |
| 2024-05-17 | Iniziato | CapitalOne | Overweight |
| 2023-08-03 | Iniziato | Robert W. Baird | Outperform |
| 2021-08-03 | Iniziato | Ladenburg Thalmann | Buy |
| 2021-07-16 | Ripresa | Maxim Group | Buy |
| 2018-09-28 | Iniziato | B. Riley FBR | Buy |
| 2018-02-15 | Reiterato | Maxim Group | Buy |
Mostra tutto
Immutep Limited Adr Borsa (IMMP) Ultime notizie
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.25% - Investing.com UK
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.25% - Investing.com
United States shares lower at close of trade; Dow Jones Industrial Average down 0.25% - Investing.com India
Crude Oil Gains Over 1%; VEON Shares Spike Higher - Benzinga
This EverCommerce analyst is no longer bullish; here are top 5 downgrades for Friday - MSN
Dow Gains Over 300 Points; US GDP Growth Revised Lower In Q4 - Benzinga
This EverCommerce Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday - Benzinga
IMMP Stock Price, Quote & Chart | IMMUTEP LTD-SP ADR (NASDAQ:IMMP) - ChartMill
Immutep Achieves 50% Enrolment in Global TACTI-004 (KEYNOTE-F91) Phase III Trial in 1L NSCLC - GlobeNewswire Inc.
Orchestra BioMed (NASDAQ:OBIO) versus Prima BioMed (NASDAQ:IMMP) Critical Analysis - Defense World
Immutep reports positive phase I data for first-in-class autoimmune antibody IMP761 - MSN
Why Immutep Limited (Common Stock) (YP1A) stock is trending on social mediaHealthcare Stock Analysis & Investment Portfolio Recommendations - Bollywood Helpline
Immutep (IMMP) reports positive IMP761 Phase I study update - Stock Titan
Why Wall Street Is Watching Immutep's Experimental Autoimmune Treatment Closely - Sahm
Will Immutep Limited Depositary Receipt stock see insider buying2025 Bull vs Bear & Accurate Intraday Trading Signals - Улправда
Why Immutep Limited (YP1B) stock is a strong analyst pickWeekly Risk Summary & AI Powered Trade Plan Recommendations - Улправда
[6-K] IMMUTEP Ltd Current Report (Foreign Issuer) | IMMP SEC FilingForm 6-K - Stock Titan
Immutep Limited (IMMP): Firm Reports Positive Data from Trials - Finviz
Ready to Jump After Recent Trade: Beta Bionics Inc (BBNX) - setenews.com
An analyst sees good growth prospects for Immutep Limited ADR (IMMP) - setenews.com
Immutep Limited Announces 2025 AGM with Key Resolutions - MSN
IMMP 20-F highlights: pipeline progress, IFRS results, Nasdaq ADSs - Stock Titan
Immutep reports Phase II neoadjuvant efti success in sarcoma via 6-K - Stock Titan
Immutep Completes FDA Project Optimus, Advances Cancer Immunotherapy - MSN
Immutep files 6-K with exhibit on FDA Project Optimus completion - Stock Titan
Immutep Announces Successful Completion of FDA Project Optimus Requirements - The Manila Times
Is Immutep Limited Depositary Receipt stock ready for a breakoutPortfolio Value Summary & Daily Volume Surge Signals - newser.com
Reversal indicators forming on Immutep Limited Depositary Receipt stockMarket Activity Summary & Safe Entry Point Alerts - newser.com
Immutep Limited (IMMP) Receives Positive FDA Feedback on Future Clinical Development of Eftilagimod Alfa - Yahoo Finance
Immutep (IMMP) Announces Positive Initial Efficacy Data and Continued Favourable Safety Data - Finviz
Immutep stock soars on promising trial results By Investing.com - Investing.com Australia
Immutep Limited (NASDAQ: IMMP)Share Price - intelligentinvestor.com.au
Which stocks are moving before the opening bell on Thursday? - ChartMill
symbol__ Stock Quote Price and Forecast - CNN
OversoldStock ScreenerCharts - Finviz
DowngradesStock ScreenerSnapshot - Finviz
Unusual VolumeStock ScreenerNews - Finviz
Top LosersStock ScreenerSnapshot - Finviz
Immutep Announces Successful Meeting with the FDA on - GlobeNewswire
Immutep Announces GMP Manufacturing Process Developed for - GlobeNewswire
ICE Announces Annual Reconstitution Changes in the ICE Biotechnology Index - Business Wire
FDA Grants Fast Track Designation to 1L Eftilagimod Alpha for Recurrent or Metastatic HNSCC - targetedonc.com
72 Biggest Movers From Friday - Benzinga
IMMP Analyst Ratings | IMMUTEP LTD-SP ADR (NASDAQ:IMMP) - ChartMill
Immutep Limited (ASX: IMM) - The Motley Fool Australia
Immutep Limited Share Price ADR each Representing 10 Shares - Hargreaves Lansdown
Technical Analysis of Immutep Ltd Sponsored ADR (NASDAQ:IMMP) - TradingView
IMM Stock Price and Chart — ASX:IMM - TradingView
IMMP - Finviz
IMMP Stock Price | Immutep Ltd. ADR Stock Quote (U.S.: Nasdaq) - MarketWatch
Prima BioMed (IMMP) Stock Price, News & Analysis - MarketBeat
Immutep Limited Adr Azioni (IMMP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.48%
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):